Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-16
1998-02-10
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549447, A61K 3136, C07D31754
Patent
active
057169845
ABSTRACT:
Novel indane and indene derivatives are described which are endothelin receptor antagonists.
REFERENCES:
patent: 3642785 (1972-02-01), Shen et al.
patent: 3737455 (1973-06-01), Shen et al.
Yamamara et al., Bull. Chem. Soc. Japan, 59, 3699 (1986).
Komendantov et al., C.A., 88:190,677p (1978).
Ihara et al., Biochem & Biophys Res. Comm., 178(1), 132-137 (1991).
Miyata et al., Journal of Antibiotics, 45(7), 1041-1046 (1992).
Koelsch, J. Org. Chem, 25, 2088 (1960).
Cousins Russell Donovan
Elliott John Duncan
Chan Nicky
Hall Linda E.
Lentz Edward T.
SmithKline Beecham Corporation
Venetianer Stephen A.
LandOfFree
Endothelin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2077745